155 related articles for article (PubMed ID: 1582440)
1. Determinants of fasting plasma triglyceride levels: metabolism of hepatic and intestinal lipoproteins.
Cortner JA; Le NA; Coates PM; Bennett MJ; Cryer DR
Eur J Clin Invest; 1992 Mar; 22(3):158-65. PubMed ID: 1582440
[TBL] [Abstract][Full Text] [Related]
2. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
[TBL] [Abstract][Full Text] [Related]
3. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
Hazzard WR; Bierman EL
Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
[TBL] [Abstract][Full Text] [Related]
4. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway.
Karpe F; Hultin M
J Lipid Res; 1995 Jul; 36(7):1557-66. PubMed ID: 7595079
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
Brunzell JD; Hazzard WR; Porte D; Bierman EL
J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
[TBL] [Abstract][Full Text] [Related]
6. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
Karpe F; Hellénius ML; Hamsten A
Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
[TBL] [Abstract][Full Text] [Related]
8. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.
Smith D; Watts GF; Dane-Stewart C; Mamo JC
Eur J Clin Invest; 1999 Mar; 29(3):204-9. PubMed ID: 10202376
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
10. Effects of estrogen/progestin agents on plasma retinoids and chylomicron remnant metabolism.
Gleeson JM; Dukes CS; Elstad NL; Chan IF; Wilson DE
Contraception; 1987 Jan; 35(1):69-78. PubMed ID: 3568661
[TBL] [Abstract][Full Text] [Related]
11. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
12. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia.
Cabezas MC; de Bruin TW; Westerveld HE; Meijer E; Erkelens DW
J Intern Med; 1998 Oct; 244(4):299-307. PubMed ID: 9797493
[TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats.
Mamo JC; Hirano T; Sainsbury A; Fitzgerald AK; Redgrave TG
Biochim Biophys Acta; 1992 Oct; 1128(2-3):132-8. PubMed ID: 1420285
[TBL] [Abstract][Full Text] [Related]
14. Hypertriglyceridemic subjects exhibit an accumulation of small dense chylomicron particles in the fasting state.
Irawati D; Mamo JC; Soares MJ; Slivkoff-Clark KM; James AP
Atherosclerosis; 2015 Nov; 243(1):236-41. PubMed ID: 26407667
[TBL] [Abstract][Full Text] [Related]
15. Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hypothesis generating study.
Peacock RE; Karpe F; Talmud PJ; Hamsten A; Humphries SE
Atherosclerosis; 1995 Jul; 116(1):135-45. PubMed ID: 7488328
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice.
Qiu S; Bergeron N; Kotite L; Krauss RM; Bensadoun A; Havel RJ
J Lipid Res; 1998 Aug; 39(8):1661-8. PubMed ID: 9717727
[TBL] [Abstract][Full Text] [Related]
17. Human intestinal lipoproteins. Studies in chyluric subjects.
Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
[TBL] [Abstract][Full Text] [Related]
18. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
19. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
20. Comparison of binding and removal of remnants of triglyceride-rich lipoproteins of intestinal and hepatic origin by rat liver in vitro.
Cooper AD; Shrewsbury MA; Erickson SK
Am J Physiol; 1982 Nov; 243(5):G389-95. PubMed ID: 7137355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]